# Geodon in Weight Loss Study for Bipolar Disorders

> **NCT00472641** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 25 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Ziprasidone/Geodon

## Key facts

- **NCT ID:** NCT00472641
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00472641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00472641, "Geodon in Weight Loss Study for Bipolar Disorders". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00472641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*